APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liganlong Granules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Liganlong Granules Industry Growth and Trends Forecast to 2032

28 December 2025123 pages

Choose your research edition.

Industry ResearchLiganlong Granules Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Liganlong Granules Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liganlong Granules Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Liganlong Granules Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Liganlong Granules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liganlong Granules include Zhongjing Wanxi Pharmaceutical Co., Ltd., Tibet Tibetan Medicine Group Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Liaoning Wohua Kangchen Pharmaceutical Co., Ltd., Liaoning Keji Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd., Jiangxi Chuanqi Pharmaceutical Co., Ltd., Jilin Yatai Pharmaceutical Co., Ltd. and Jilin Yinoke Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Liganlong Granules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liganlong Granules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liganlong Granules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liganlong Granules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liganlong Granules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liganlong Granules Market by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Tibet Tibetan Medicine Group Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jiangxi Chuanqi Pharmaceutical Co., Ltd.

Jilin Yatai Pharmaceutical Co., Ltd.

Jilin Yinoke Pharmaceutical Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.

Hainan Zhongbao Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Guizhou Dalong Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Guangxi Xiuzhen Pharmaceutical Co., Ltd.

Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.

Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.

Dalian Meiluo Chinese Medicine Factory Co., Ltd.

Dalian Hanfang Pharmaceutical Co., Ltd.

Liganlong Granules Segment by Type

5g

10g

Liganlong Granules Segment by Application

Hospital

Clinic

Other

Liganlong Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liganlong Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liganlong Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liganlong Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liganlong Granules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liganlong Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5g Table 2. Major Company of 10g Table 3. Global Liganlong Granules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 5. Global Liganlong Granules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Liganlong Granules Sales Market Share in Value by Type (2021-2026) Table 8. Global Liganlong Granules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 10. Global Liganlong Granules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Liganlong Granules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Liganlong Granules Sales Market Share in Value by Type (2027-2032) Table 13. Global Liganlong Granules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 15. North America Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 17. Europe Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Liganlong Granules Sales by Type (2021-2026) & (US$ Million) Table 24. Liganlong Granules Industry Trends Table 25. Liganlong Granules Industry Drivers Table 26. Liganlong Granules Industry Opportunities and Challenges Table 27. Liganlong Granules Industry Restraints Table 28. Global Liganlong Granules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Liganlong Granules Revenue Market Share by Company (2021-2026) Table 30. Global Liganlong Granules Sales by Company (2021-2026) & (K Units) Table 31. Global Liganlong Granules Sales Share by Company (2021-2026) Table 32. Global Liganlong Granules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Liganlong Granules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Liganlong Granules Major Company Production Sites and Headquarters Table 35. Global Liganlong Granules Company, Product Type & Application Table 36. Global Liganlong Granules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Liganlong Granules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Liganlong Granules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Liganlong Granules Sales by Region (2021-2026) & (K Units) Table 41. Global Liganlong Granules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Liganlong Granules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Liganlong Granules Sales Market Share in Value by Region (2021-2026) Table 44. Global Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Liganlong Granules Sales by Region (2027-2032) & (K Units) Table 46. Global Liganlong Granules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Liganlong Granules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Liganlong Granules Sales Market Share in Value by Region (2027-2032) Table 49. Global Liganlong Granules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Liganlong Granules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 52. Global Liganlong Granules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Liganlong Granules Sales Market Share in Value by Application (2021-2026) Table 55. Global Liganlong Granules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 57. Global Liganlong Granules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Liganlong Granules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Liganlong Granules Sales Market Share in Value by Application (2027-2032) Table 60. Global Liganlong Granules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 62. North America Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 64. Europe Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Liganlong Granules Sales by Application (2021-2026) & (US$ Million) Table 71. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 72. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 73. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 75. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Development Table 76. Tibet Tibetan Medicine Group Co., Ltd. Company Information Table 77. Tibet Tibetan Medicine Group Co., Ltd. Business Overview Table 78. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio Table 80. Tibet Tibetan Medicine Group Co., Ltd. Recent Development Table 81. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 82. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 83. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 85. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 86. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information Table 87. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview Table 88. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 90. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Development Table 91. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 92. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 93. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 95. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 96. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 97. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 98. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 100. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 101. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information Table 102. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview Table 103. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 105. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Development Table 106. Jilin Yatai Pharmaceutical Co., Ltd. Company Information Table 107. Jilin Yatai Pharmaceutical Co., Ltd. Business Overview Table 108. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 110. Jilin Yatai Pharmaceutical Co., Ltd. Recent Development Table 111. Jilin Yinoke Pharmaceutical Co., Ltd. Company Information Table 112. Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview Table 113. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 115. Jilin Yinoke Pharmaceutical Co., Ltd. Recent Development Table 116. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 117. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 118. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 120. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Development Table 121. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information Table 122. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview Table 123. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 125. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development Table 126. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information Table 127. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview Table 128. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 130. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Development Table 131. Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information Table 132. Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview Table 133. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 135. Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Development Table 136. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 137. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 138. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 140. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 141. Guizhou Dalong Pharmaceutical Co., Ltd. Company Information Table 142. Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview Table 143. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 145. Guizhou Dalong Pharmaceutical Co., Ltd. Recent Development Table 146. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 147. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 148. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 150. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 151. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information Table 152. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview Table 153. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 155. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Development Table 156. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information Table 157. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview Table 158. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 160. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Development Table 161. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information Table 162. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview Table 163. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio Table 165. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Development Table 166. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information Table 167. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview Table 168. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio Table 170. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Development Table 171. Dalian Hanfang Pharmaceutical Co., Ltd. Company Information Table 172. Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview Table 173. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 175. Dalian Hanfang Pharmaceutical Co., Ltd. Recent Development Table 176. North America Liganlong Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. North America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 178. North America Liganlong Granules Sales Market Share by Country (2021-2026) Table 179. North America Liganlong Granules Sales Forecast by Country (2027-2032) & (K Units) Table 180. North America Liganlong Granules Sales Market Share Forecast by Country (2027-2032) Table 181. North America Liganlong Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Liganlong Granules Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Liganlong Granules Market Share by Country (2021-2026) Table 184. North America Liganlong Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Liganlong Granules Market Share Forecast by Country (2027-2032) Table 186. Europe Liganlong Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Europe Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 188. Europe Liganlong Granules Sales Market Share by Country (2021-2026) Table 189. Europe Liganlong Granules Sales Forecast by Country (2027-2032) & (K Units) Table 190. Europe Liganlong Granules Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Liganlong Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Liganlong Granules Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Liganlong Granules Market Share by Country (2021-2026) Table 194. Europe Liganlong Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Liganlong Granules Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Liganlong Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 198. Asia-Pacific Liganlong Granules Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Liganlong Granules Sales Forecast by Country (2027-2032) & (K Units) Table 200. Asia-Pacific Liganlong Granules Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Liganlong Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Liganlong Granules Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Liganlong Granules Market Share by Country (2021-2026) Table 204. Asia-Pacific Liganlong Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Liganlong Granules Market Share Forecast by Country (2027-2032) Table 206. Latin America Liganlong Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Latin America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 208. Latin America Liganlong Granules Sales Market Share by Country (2021-2026) Table 209. Latin America Liganlong Granules Sales Forecast by Country (2027-2032) & (K Units) Table 210. Latin America Liganlong Granules Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Liganlong Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Liganlong Granules Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Liganlong Granules Market Share by Country (2021-2026) Table 214. Latin America Liganlong Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Liganlong Granules Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Liganlong Granules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 218. Middle East and Africa Liganlong Granules Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Liganlong Granules Sales Forecast by Country (2027-2032) & (K Units) Table 220. Middle East and Africa Liganlong Granules Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Liganlong Granules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Liganlong Granules Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Liganlong Granules Market Share by Country (2021-2026) Table 224. Middle East and Africa Liganlong Granules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Liganlong Granules Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Liganlong Granules Distributors List Table 229. Liganlong Granules Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Liganlong Granules Image Figure 2. Global Liganlong Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liganlong Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Liganlong Granules Sales (2021-2032) & (K Units) Figure 5. 5g Image Figure 6. Global 5g Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10g Image Figure 8. Global 10g Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Liganlong Granules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Liganlong Granules Market Share by Type 2025 VS 2032 Figure 11. North America Liganlong Granules Sales Market Share in Volume by Type in 2025 Figure 12. North America Liganlong Granules Sales Market Share in Value by Type in 2025 Figure 13. Europe Liganlong Granules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Liganlong Granules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Liganlong Granules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Liganlong Granules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Liganlong Granules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Liganlong Granules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Liganlong Granules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Liganlong Granules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Liganlong Granules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Liganlong Granules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Liganlong Granules Market Share by Application 2025 VS 2032 Figure 31. North America Liganlong Granules Sales Market Share in Volume by Application in 2025 Figure 32. North America Liganlong Granules Sales Market Share in Value by Application in 2025 Figure 33. Europe Liganlong Granules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Liganlong Granules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Liganlong Granules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Liganlong Granules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Liganlong Granules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Liganlong Granules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Liganlong Granules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Liganlong Granules Sales Market Share in Value by Application in 2025 Figure 41. North America Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Liganlong Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Liganlong Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Liganlong Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Liganlong Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Liganlong Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Liganlong Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Liganlong Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Liganlong Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Liganlong Granules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Liganlong Granules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Liganlong Granules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Liganlong Granules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Liganlong Granules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Liganlong Granules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 5g
  • 10g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Tibet Tibetan Medicine Group Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  • Jilin Yatai Pharmaceutical Co., Ltd.
  • Jilin Yinoke Pharmaceutical Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  • Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  • Hainan Zhongbao Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Guizhou Dalong Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  • Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  • Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  • Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  • Dalian Hanfang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liganlong Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liganlong Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liganlong Granules Market by Type
  6. 1.3.1 5g
  7. 1.3.2 10g
  8. 1.4 Global Liganlong Granules Market Size by Type
  9. 1.4.1 Global Liganlong Granules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Liganlong Granules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Liganlong Granules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Liganlong Granules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Liganlong Granules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Liganlong Granules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Liganlong Granules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Liganlong Granules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liganlong Granules Industry Trends
  2. 2.2 Liganlong Granules Industry Drivers
  3. 2.3 Liganlong Granules Industry Opportunities and Challenges
  4. 2.4 Liganlong Granules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liganlong Granules Revenue (2021-2026)
  2. 3.2 Global Top Players by Liganlong Granules Sales (2021-2026)
  3. 3.3 Global Top Players by Liganlong Granules Price (2021-2026)
  4. 3.4 Global Liganlong Granules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liganlong Granules Major Company Production Sites & Headquarters
  6. 3.6 Global Liganlong Granules Company, Product Type & Application
  7. 3.7 Global Liganlong Granules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liganlong Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liganlong Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liganlong Granules Tier 1, Tier 2, and Tier 3
4 Liganlong Granules Regional Status and Outlook
  1. 4.1 Global Liganlong Granules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liganlong Granules Historic Market Size by Region
  3. 4.2.1 Global Liganlong Granules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liganlong Granules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liganlong Granules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liganlong Granules Forecasted Market Size by Region
  7. 4.3.1 Global Liganlong Granules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liganlong Granules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liganlong Granules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liganlong Granules by Application
  1. 5.1 Liganlong Granules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Liganlong Granules Market Size by Application
  6. 5.2.1 Global Liganlong Granules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Liganlong Granules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Liganlong Granules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Liganlong Granules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Liganlong Granules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Liganlong Granules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Liganlong Granules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Liganlong Granules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 6.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  6. 6.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Tibet Tibetan Medicine Group Co., Ltd.
  8. 6.2.1 Tibet Tibetan Medicine Group Co., Ltd. Company Information
  9. 6.2.2 Tibet Tibetan Medicine Group Co., Ltd. Business Overview
  10. 6.2.3 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio
  12. 6.2.5 Tibet Tibetan Medicine Group Co., Ltd. Recent Developments
  13. 6.3 Sichuan Luye Pharmaceutical Co., Ltd.
  14. 6.3.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  18. 6.3.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  20. 6.4.1 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  24. 6.4.5 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Liaoning Keji Pharmaceutical Co., Ltd.
  26. 6.5.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  30. 6.5.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Liaoning Dongyi Pharmaceutical Co., Ltd.
  32. 6.6.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  36. 6.6.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  38. 6.7.1 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  42. 6.7.5 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Jilin Yatai Pharmaceutical Co., Ltd.
  44. 6.8.1 Jilin Yatai Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Jilin Yatai Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  48. 6.8.5 Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jilin Yinoke Pharmaceutical Co., Ltd.
  50. 6.9.1 Jilin Yinoke Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  54. 6.9.5 Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  56. 6.10.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  60. 6.10.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  62. 6.11.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  66. 6.11.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  68. 6.12.1 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  72. 6.12.5 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Hainan Zhongbao Pharmaceutical Co., Ltd.
  74. 6.13.1 Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  78. 6.13.5 Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  80. 6.14.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  84. 6.14.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Guizhou Dalong Pharmaceutical Co., Ltd.
  86. 6.15.1 Guizhou Dalong Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  90. 6.15.5 Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  92. 6.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  96. 6.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  98. 6.17.1 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  102. 6.17.5 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  104. 6.18.1 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  108. 6.18.5 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  110. 6.19.1 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information
  111. 6.19.2 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview
  112. 6.19.3 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio
  114. 6.19.5 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments
  115. 6.20 Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  116. 6.20.1 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information
  117. 6.20.2 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview
  118. 6.20.3 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio
  120. 6.20.5 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments
  121. 6.21 Dalian Hanfang Pharmaceutical Co., Ltd.
  122. 6.21.1 Dalian Hanfang Pharmaceutical Co., Ltd. Company Information
  123. 6.21.2 Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview
  124. 6.21.3 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  126. 6.21.5 Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Liganlong Granules Sales by Country
  2. 7.1.1 North America Liganlong Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liganlong Granules Sales by Country (2021-2026)
  4. 7.1.3 North America Liganlong Granules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liganlong Granules Market Size by Country
  6. 7.2.1 North America Liganlong Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liganlong Granules Market Size by Country (2021-2026)
  8. 7.2.3 North America Liganlong Granules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liganlong Granules Sales by Country
  2. 8.1.1 Europe Liganlong Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liganlong Granules Sales by Country (2021-2026)
  4. 8.1.3 Europe Liganlong Granules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liganlong Granules Market Size by Country
  6. 8.2.1 Europe Liganlong Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liganlong Granules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liganlong Granules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liganlong Granules Sales by Country
  2. 9.1.1 Asia-Pacific Liganlong Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liganlong Granules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liganlong Granules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liganlong Granules Market Size by Country
  6. 9.2.1 Asia-Pacific Liganlong Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liganlong Granules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liganlong Granules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liganlong Granules Sales by Country
  2. 10.1.1 South America Liganlong Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liganlong Granules Sales by Country (2021-2026)
  4. 10.1.3 South America Liganlong Granules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liganlong Granules Market Size by Country
  6. 10.2.1 South America Liganlong Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liganlong Granules Market Size by Country (2021-2026)
  8. 10.2.3 South America Liganlong Granules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liganlong Granules Sales by Country
  2. 11.1.1 Middle East and Africa Liganlong Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liganlong Granules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liganlong Granules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liganlong Granules Market Size by Country
  6. 11.2.1 Middle East and Africa Liganlong Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liganlong Granules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liganlong Granules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liganlong Granules Value Chain Analysis
  2. 12.1.1 Liganlong Granules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liganlong Granules Production Mode & Process
  7. 12.2 Liganlong Granules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liganlong Granules Distributors
  10. 12.2.3 Liganlong Granules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst